Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Sep;61(9):1340-54.
doi: 10.1136/gutjnl-2011-301897. Epub 2012 Jun 8.

Diagnosis and Management of Patients With Reflux Symptoms Refractory to Proton Pump Inhibitors

Affiliations
Review

Diagnosis and Management of Patients With Reflux Symptoms Refractory to Proton Pump Inhibitors

Daniel Sifrim et al. Gut. .

Abstract

Approximately a third of patients with suspected gastro-oesophageal reflux disease are resistant or partial responders to proton pump inhibitors (PPIs). Many of these patients do not have gastro-oesophageal reflux disease, but suffer from functional heartburn or dyspepsia. The potential mechanisms underlying failure of PPI treatment in patients with reflux-related symptoms include persistence of isolated or mixed acid, weakly acidic, bile or gas reflux, impaired oesophageal mucosal integrity, chemical or mechanical hypersensitivity to refluxates and psychological comorbidity. After thorough clinical evaluation and failure of empirical changes in PPI dose regime, diagnostic investigations include endoscopy and reflux monitoring with pH or pH-impedance monitoring. If symptoms are clearly related to persistent reflux, baclofen, antireflux surgery or pain modulators can be considered. If not, pain modulators are the only currently available therapy.

Similar articles

See all similar articles

Cited by 71 articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback